Just under 20% of Americans have rapid access to endovascular thrombectomy for stroke, according to a study out of the University of Texas Health Science Center at Houston.
The Beloit, Wisconsin-based company has received exclusive rights from Capella Imaging to develop and investigate a new fibrin-targeted diagnostic agent that's used in heart imaging exams.
Online pharmacy Valisure submitted a petition to the FDA on March 2 to recall and investigate several lots of metformin, one of the most widely used diabetes drugs today, Bloomberg reports.
He will take the helm as the publication's editor-in-chief beginning in July, when longtime AJR Editor Thomas H. Berquist, MD, leaves for retirement, the American Roentgen Ray Society announced this month.
INFINITT will also demonstrate its superior integration capabilities at the ‘Interoperability Showcase’ from March 10-12th, enabling visitors to see INFINITT systems exchanging data with other vendors in real time.
A small-scale study published in Circulation March 3 has revealed a potential new culprit behind sudden cardiac death in patients with arrhythmogenic right ventricular cardiomyopathy: integrin β1D.
ECR 2020 was set to kick off next Wednesday, March 11, in Vienna. However, society leaders were “forced to make this decision” almost a week prior to the start date, given recent warnings issued by the WHO and others.
A probable carcinogen NDMA has been found in a diabetes drug metformin, testing by a pharmacy has confirmed. The FDA previously announced it was testing metformin, which helps control blood sugar, for NDMA.
